Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Axogen Inc (AXGN)  
$5.98 0.11 (1.87%) as of 4:30 Thu 5/9


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 41,560,000
Market Cap: 248.53(M)
Last Volume: 5,200 Avg Vol: 5,186
52 Week Range: $3.61 - $10.69
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Appliances & Equipment

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Axogen is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Co.'s platform for peripheral nerve repair features a portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; and Axoguard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Co. also provides Axotouch Two-Point Discriminator, which is used to measure the innervation density of any surface area of the skin.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 30,000 30,000
Total Buy Value $0 $0 $188,940 $188,940
Total People Bought 0 0 3 3
Total Buy Transactions 0 0 3 3
Total Shares Sold 118,082 130,582 180,030 368,410
Total Sell Value $980,899 $1,074,708 $1,509,387 $3,484,755
Total People Sold 5 6 6 6
Total Sell Transactions 6 7 9 21
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 470
  Page 7 of 19  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Devinney Erick Wayne VP Peripheral Nerve Science   •       –      –    2022-02-15 4 D $8.42 $3,006 D/D (357) 88,075     -
   Devinney Erick Wayne VP Peripheral Nerve Science   •       –      –    2022-02-15 4 A $0.00 $0 D/D 1,181 88,432     -
   Billet Isabelle Chief Strategy and BD Officer   •       –      –    2021-12-27 4 D $9.74 $3,175 D/D (326) 14,184     -
   Billet Isabelle Chief Strategy and BD Officer   •       –      –    2021-12-27 4 OE $0.00 $0 D/D 1,150 14,510     -
   Donovan Michael Patrick VP Operations   •       –      –    2021-12-27 4 D $9.74 $2,786 D/D (286) 41,983     -
   Donovan Michael Patrick VP Operations   •       –      –    2021-12-27 4 OE $0.00 $0 D/D 1,150 42,269     -
   Mariani Peter J EVP & Chief Financial Officer   •       –      –    2021-12-27 4 D $9.74 $6,312 D/D (648) 24,146     -
   Mariani Peter J EVP & Chief Financial Officer   •       –      –    2021-12-27 4 OE $0.00 $0 D/D 2,625 24,794     -
   Friedman Mark Louis VP Regulatory Affairs & Policy   •       –      –    2021-12-27 4 D $9.74 $2,786 D/D (286) 17,452     -
   Friedman Mark Louis VP Regulatory Affairs & Policy   •       –      –    2021-12-27 4 OE $0.00 $0 D/D 1,150 17,738     -
   Zaderej Karen L. CEO   •       •      –    2021-12-27 4 D $9.74 $17,064 D/D (1,752) 925,677     -
   Zaderej Karen L. CEO   •       •      –    2021-12-27 4 OE $0.00 $0 D/D 4,400 927,429     -
   Devinney Erick Wayne VP Peripheral Nerve Science   •       –      –    2021-12-27 4 D $9.74 $1,821 D/D (187) 87,249     -
   Devinney Erick Wayne VP Peripheral Nerve Science   •       –      –    2021-12-27 4 OE $0.00 $0 D/D 750 87,436     -
   Scopelianos Angelo Chief R&D Officer   •       –      –    2021-12-27 4 D $9.74 $2,786 D/D (286) 10,984     -
   Scopelianos Angelo Chief R&D Officer   •       –      –    2021-12-27 4 OE $0.00 $0 D/D 1,150 11,270     -
   Martinez Maria D. Chief Human Resources Officer   •       –      –    2021-12-27 4 D $9.74 $2,786 D/D (286) 5,731     -
   Martinez Maria D. Chief Human Resources Officer   •       –      –    2021-12-27 4 OE $0.00 $0 D/D 1,150 6,017     -
   Donovan Michael Patrick VP Operations   •       –      –    2021-12-20 4 D $9.24 $878 D/D (95) 41,119     -
   Donovan Michael Patrick VP Operations   •       –      –    2021-12-20 4 OE $0.00 $0 D/D 375 41,214     -
   Mariani Peter J EVP & Chief Financial Officer   •       –      –    2021-12-20 4 D $9.24 $6,995 D/D (757) 22,169     -
   Mariani Peter J EVP & Chief Financial Officer   •       –      –    2021-12-20 4 OE $0.00 $0 D/D 1,900 22,926     -
   Friedman Mark Louis VP Regulatory Affairs & Policy   •       –      –    2021-12-20 4 D $9.24 $878 D/D (95) 16,588     -
   Friedman Mark Louis VP Regulatory Affairs & Policy   •       –      –    2021-12-20 4 OE $0.00 $0 D/D 375 16,683     -
   Zaderej Karen L. CEO   •       •      –    2021-12-20 4 D $9.24 $11,485 D/D (1,243) 923,029     -
  470 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 7 of 19
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us